Rapid high-content imaging drives therapeutic success

Araceli Biosciences is on a mission to create cutting-edge imaging platforms that empower researchers to accelerate their therapeutic discovery. In this interview, CEO Matt Beaudet and Product Manager Nasiema Wingate-Pearse discuss the industry shifts shaping their innovations and how the Endeavor™ High Content Screening Platforms address critical research challenges. Learn what distinguishes Araceli’s technology, how they support scientists beyond instrumentation, and what excites them the most about the future of therapeutic research.

Plus, request a demo here.

This video was filmed at SLAS Europe 2025.